Filing Details
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) filed a Form 8-K with the Securities and Exchange Commission on July 16, 2026, disclosing a material event.
8k filedNASDAQ:HRMY
Harmony Biosciences Holdings, Inc. (HRMY) Reports Material Event to SEC
Filing Details Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) filed a Form 8-K with the Securities and Exchange Commission on July 16, 2026, disclosing a material event. Market…
Market Context
Harmony Biosciences Holdings, Inc.'s stock currently trades at $33.53 with a market capitalization of $2.3B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Harmony Biosciences Holdings, Inc.'s stock.
All SEC filings for Harmony Biosciences Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View HRMY Stock Page
Frequently Asked Questions
Where can I read HRMY's SEC filings?
Browse all filings on our HRMY SEC filings page.
What types of SEC filings does Harmony Biosciences Holdings, Inc. file?
Public companies like Harmony Biosciences Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.